Delay in financial results for the year ended 31st March, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indrayani Biotech Ltd has informed BSE that it will miss the regulatory deadline of 30th May 2026 for submitting its audited financial results (standalone and consolidated) for Q4 and FY2026. The company cites three reasons for the delay: (1) consolidation of results from subsidiaries, (2) operational disruptions, and (3) internal and external audit processes taking longer than expected. The Board meeting to approve the results will be held at a later date. The company has also closed its Trading Window for Designated Persons until 48 hours after the results are declared. No actual financial figures or performance data are provided in this intimation.
This is a procedural delay intimation rather than a financial results announcement. The mention of 'operational disruptions' may raise concerns about business conditions, but the filing contains no specific guidance on financials or earnings quality. Investors should await the actual results for any material assessment.